Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
7,461
Value
$347.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SUPN by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,461$347.0K<0.1%−13−0.2%ReducedHolders
Q1 20267,474$386.3K<0.1%00.0%UnchangedHolders
Q4 20257,474$371.5K<0.1%−23−0.3%ReducedHolders
Q3 20257,497$358.3K<0.1%+5+0.1%AddedHolders
Q2 20257,492$236.1K<0.1%+705+10.4%AddedHolders
Q1 20256,787$222.3K<0.1%+5,316+361.4%AddedHolders
Q4 20241,471$53.2K<0.1%00.0%UnchangedHolders
Q3 20241,471$45.9K<0.1%00.0%UnchangedHolders
Q2 20241,471$39.4K<0.1%−817−35.7%ReducedHolders
Q1 20242,288$78.0K<0.1%+839+57.9%AddedHolders
Q4 20231,449$41.9K<0.1%+1,330+1,117.6%AddedHolders
Q3 2023119$3.28K<0.1%−188−61.2%ReducedHolders
Q2 2023307$9.23K<0.1%+38+14.1%AddedHolders
Q1 2023269$9.75K<0.1%+100+59.2%AddedHolders
Q4 2022169$6.03K<0.1%−373−68.8%ReducedHolders
Q3 2022542$18.0K<0.1%+400+281.7%AddedHolders
Q2 2022142$4.00K<0.1%+13+10.1%AddedHolders
Q1 2022129$4.00K<0.1%00.0%UnchangedHolders
Q4 2021129$4.00K<0.1%−21−14.0%ReducedHolders
Q3 2021150$4.00K<0.1%+14+10.3%AddedHolders
Q2 2021136$4.00K<0.1%+7+5.4%AddedHolders
Q1 2021129$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.